Kana Hasegawa (Cellular Immunotherapy, IFReC), Naoki Hosen (IFReC/Graduate school of Medicine, Osaka University), and their research group discovered a new antibody R8H283, which recognizes CD98hc on multiple myeloma.

Commentary (PDF)


Article (External Link)

Contact:

Naoki Hosen (Cellular Immunotherapy)

+81-6-6879-3871
hnaokbldon.med.osaka-u.ac.jp

Immunology Frontier Research Center, Osaka University (WPI-IFReC)